Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000148.xml
Flugmedizin · Tropenmedizin · Reisemedizin - FTR 2023; 30(04): 168-208
DOI: 10.1055/a-2102-7318
DOI: 10.1055/a-2102-7318
Tropenmedizin
Empfehlungen zur Malariaprophylaxe
Recommendations for antimalarial prophylaxis
Keywords
travel medicine - malaria - repellents - chemoprophylaxis - pediatric travelers - pregnant travelersPublication History
Article published online:
09 August 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Word. Health Organization. World Malaria Report 2022. Geneva: WHO; 2022
- 2 Falkenhorst G. RKI, Persönliche Kommunikation. 2023
- 3 Schlabe S, Reiter-Owona I, Nordmann T. et al Rapid diagnostic test negative Plasmodium falciparum malaria in a traveller returning from Ethiopia. Malar J 2021; 20: 145 DOI: 10.1186/s12936-021-03678-2.
- 4 Parr JB, Verity R, Doctor SM. et al Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey. J Infect Dis 2017; 216: 36-44 DOI: 10.1093/infdis/jiw538.
- 5 Plucinski MM, Herman C, Jones S. et al Screening for Pfhrp2/3-Deleted Plasmodium falciparum, Non-falciparum, and Low-Density Malaria Infections by a Multiplex Antigen Assay. J Infect Dis 2019; 219: 437-447 DOI: 10.1093/infdis/jiy525.
- 6 Feleke SM, Reichert EN. Mohammed, et al Plasmodium falciparum is evolving to escape malaria rapid diagnostic tests in Ethiopia. Nat Microbiol 2021; 06: 1289-1299 DOI: 10.1038/s41564-021-00962-4.
- 7 World Health Organization. Malaria Threats Maps. Im Internet www.who.int/teams/global-malaria-programme/surveillance/malaria-threats-map
- 8 Sinka ME, Pironon S, Massey NC. et al A new malaria vector in Africa: Predicting the expansion range of Anopheles stephensi and identifying the urban populations at risk. Proc Natl Acad Sci U S A 2020; 117: 24900-24908 DOI: 10.1073/pnas.2003976117.
- 9 Whittaker C, Hamlet A, Sherrard-Smith E. et al Seasonal dynamics of Anopheles stephensi and its implications for mosquito detection and emergent malaria control in the Horn of Africa. Proc Natl Acad Sci U S A 2023; 120: e2216142120 DOI: 10.1073/pnas.2216142120.
- 10 World Health Organization. Vector alert: Anopheles stephensi invasion and spread in Africa and Sri Lanka. 27 January 2023. Im Internet https://www.who.int/publications/i/item/9789240067714
- 11 Kweka EJ. Anopheles stephensi: a guest to watch in urban Africa. Trop Dis Travel Med Vaccines 2022; 08: 7 DOI: 10.1186/s40794-022-00165-7.
- 12 Takken W, Lindsay S. Increased Threat of Urban Malaria from Anopheles stephensi Mosquitoes, Africa. Emerg Infect Dis 2019; 25: 1431-1433 DOI: 10.3201/eid2507.190301.
- 13 Benz U, Traore MM, Revay EE. et al Verringern helle Textilien die Stichrate von Vektor-Mücken? Eine simulierte Feldstudie aus Mali, Westafrika. Konferenz für Infektionskrankheiten und Tropenemedizin (KIT), Leipzig. 2023
- 14 Fradin MS.. Insect Protection. In: Keystone JS, Kozarsky PE, Connor BA, Nothdurft HD, Mendelson M, Leder K (eds.). Travel Medicine. 4th ed.: Elsevier 2019: 43-52
- 15 The Medical Letter Inc. Insect Repellents. Insect Repellents. The Medical Letter on Drugs and Therapeutics 2019; 61 (Issue 1579)
- 16 Chiodini PL, Patel D, Goodyer L, Ranson H. Guidelines for malaria prevention in travellers from the United Kingdom 2022. London: Public Health England; 2022
- 17 Stanczyk NM, Behrens RH, Chen-Hussey V. et al Mosquito repellents for travellers. BMJ 2015; 350: h99 DOI: 10.1136/bmj.h99.
- 18 Lupi E, Hatz C, Schlagenhauf P. The efficacy of repellents against Aedes, Anopheles, Culex and Ixodes spp. – a literature review. Travel Med Infect Dis 2013; 11: 374-411 DOI: 10.1016/j.tmaid.2013.10.005.
- 19 Ferrara P, Masuet-Aumatell C, Agüero F. et al The use of stand-by emergency treatment (SBET) for malaria in travellers: A systematic review and meta-analysis of observational studies. J Infect 2018; 77: 455-462 DOI: 10.1016/j.jinf.2018.09.007.
- 20 Ferrara P, Masuet-Aumatell C, Agüero F. et al Stand-by emergency treatment (SBET) of malaria in Spanish travellers: a cohort study. Malar J 2018; 17: 134 DOI: 10.1186/s12936-018-2304-7.
- 21 Tan R, Elmers J, Genton B. Malaria standby emergency treatment (SBET) for travellers visiting malaria endemic areas: a systematic review and meta-analysis. J Travel Med 2019; 26: taz027 DOI: 10.1093/jtm/taz027.
- 22 Vinnemeier CD, Rothe C, Kreuels B. et al Response to fever and utilization of standby emergency treatment (SBET) for malaria in travellers to Southeast Asia: a questionnaire-based cohort study. Malar J 2017; 16: 44 DOI: 10.1186/s12936-017-1678-2.
- 23 Gaillard T, Briolant S, Madamet M. et al The end of a dogma: the safety of doxycycline use in young children for malaria treatment. Malar J 2017; 16: 148 DOI: 10.1186/s12936-017-1797-9.
- 24 Chelapharm. Educational Material Lariam. Österreich – Behördlich beauftragtes Schulungsmaterial für medizinisches Fachpersonal für Lariam 250 mg, Tablette. Im Internet https://www.cheplapharm.com/educational-material/lariam/
- 25 Kurth F, Lingscheid T, Steiner F. et al Hemolysis after Oral Artemisinin Combination Therapy for Uncomplicated Plasmodium falciparum Malaria. Emerg Infect Dis 2016; 22: 1381-1386 DOI: 10.3201/eid2208.151905.
- 26 Health Belgium. Avis 9158 patients ID et vaccination. 09/10/2019. Im Internet www.health.belgium.be/fr/avis-9158-patients-id-et-vaccination
- 27 Froeschl G, Nothdurft HD, von Sonnenburg F. et al Retrospective clinical case series study in 2017 identifies Plasmodium knowlesi as most frequent Plasmodium species in returning travellers from Thailand to Germany. Euro Surveill 2018; 23: 1700619 DOI: 10.2807/1560-7917.ES.2018.23.29.1700619.
- 28 Schwartz E, Parise M, Kozarsky P. et al Delayed onset of malaria – implications for chemoprophylaxis in travelers. N Engl J Med 2003; 349: 1510-1516 DOI: 10.1056/NEJMoa021592.
- 29 Baird JK. Tafenoquine for travelers’ malaria: evidence, rationale and recommendations. J Travel Med 2018; 25: tay110 DOI: 10.1093/jtm/tay110.
- 30 Pays JF. Threats to the Effectiveness of Malaria Treatment. Bull Soc Pathol Exot 2018; 111: 197-198 DOI: 10.3166/bspe-2018-0046.
- 31 Ashley EA, Pyae Phyo A, Woodrow CJ. Malaria. Lancet 2018; 391: 1608-1621 DOI: 10.1016/S0140-6736(18)30324-6.
- 32 Grobusch MP, Kremsner PG. Uncomplicated malaria. Curr Top Microbiol Immunol 2005; 295: 83-104
- 33 Wilson ME, Weld LH, Boggild A. et al Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis 2007; 44: 1560-1568 DOI: 10.1086/518173.
- 34 DTG. Leitlinie: Diagnostik und Therapie der Malaria. Version Februar 2021. Im Internet https://www.awmf.org/uploads/tx_szleitlinien/042-001l_S1_Diagnostik-Therapie-Malaria_2021-08.pdf
- 35 Froeschl G, Beissner M, Huber K. et al Plasmodium knowlesi infection in a returning German traveller from Thailand: a case report on an ermerging malaria pathogen in a popular low-risk travel destination. BMC Infect Dis 2018; 18: 148 DOI: 10.1186/s12879-018-3059-z.
- 36 Emryotox.de. Doxycyclin. Im Internet https://www.embryotox.de/arzneimittel/details/doxycyclin/
- 37 HIV Drug interactions. Im Internet www.hiv-druginteractions.org
- 38 Infrastruktur BfVud (ed.). Seeärztlicher Dienst DSBV. Malaria-Merkblatt. Hamburg; 2018: 8
- 39 World Health Organization. International Medical Guide for Ships. 3rd ed. 2007. Im Internet https://apps.who.int/iris/bitstream/handle/10665/43814/9789240682313_eng.pdf?sequence=1
- 40 World Health Organization Malaria vaccine: WHO position paper – March 2022. Wkly Epid Rec 2022; 97: 61-80
- 41 Mordmuller B, Supan C, Sim KL. et al Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres. Malar J 2015; 14: 117 DOI: 10.1186/s12936-015-0628-0.
- 42 Mordmuller B, Surat G, Lagler H. et al Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature 2017; 542: 445-449 DOI: 10.1038/nature21060.
- 43 Lyke KE, Ishizuka AS, Berry AA. et al Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proc Natl Acad Sci U S A 2017; 114: 2711-2716 DOI: 10.1073/pnas.1615324114.
- 44 Gaudinski MR, Berkowitz NM, Idris AH. et al A Monoclonal Antibody for Malaria Prevention. N Engl J Med 2021; 385: 803-814 DOI: 10.1056/NEJMoa2034031.
- 45 Lyke KE, Berry AA, Mason K. et al Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial. Lancet Infect Dis 2023; 23: 578-588 DOI: 10.1016/S1473-3099(22)00793-9.
- 46 Wu RL, Idris AH, Berkowitz NM. et al Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria. N Engl J Med 2022; 387: 397-407 DOI: 10.1056/NEJMoa2203067.
- 47 Kayentao K, Ongoiba A, Preston AC. et al Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali. N Engl J Med 2022; 387: 1833-1842 DOI: 10.1056/NEJMoa2206966.
- 48 World Health Organization. Countries with risk of yellow fever transmission and countries requiring proof of vaccination against yellow fever. (Revised on 3 January 2023). Im Internet https://cdn.who.int/media/docs/default-source/travel-and-health/countries-with-risk-of-yellow-fever-transmission.pdf
- 49 World Health Organization. Countries and territories certified malaria-free by WHO. Im Internet https://www.who.int/teams/global-malaria-programme/elimination/countries-and-territories-certified-malaria-free-by-who